Incidence of vaginal toxicities following definitive chemoradiation in intact cervical cancer: A meta-analysis
Journal of Contemporary Brachytherapy · 2024 · 16 (3) · 241-256
DOI: 10.5114/jcb.2024.141402 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Contemporary Brachytherapy, 2024. Verfasst von Shraddha Raj und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Purpose
Cervical cancer is a significant global health burden, with advancements in treatment modalities improving outcomes. However, vaginal toxicities following definitive chemoradiation remain a concern, impacting patients' quality of life. The aim of this systematic review and meta-analysis was to estimate the incidence of vaginal toxicities, explore associated factors, and assess the relationship with radiation dose in intact cervical cancer patients undergoing radical chemoradiation. Material and methods: A systematic search of PubMed, Google Scholar, and Cochrane databases was conducted. Studies reporting on vaginal toxicities post-radical chemoradiation in intact cervical cancer patients were included. Data extraction and analysis were performed according to PRISMA guidelines.
Results
Twenty-four studies with various designs were included. The meta-analysis revealed a pooled estimate of 39% (95% CI: 21-56%) for overall vaginal toxicities among cervical cancer patients following definitive chemoradiation. Vaginal stenosis was the most commonly reported toxicity, with a median incidence of 61.5% (range, 20-77.8%) across the studies. Severe toxicities (grade ≥ 3) were reported at rates of 12.74% (CTCAE v. 4.0), 0.98% (CTCAE v. 3.0), 10.41% (RTOG/EORTC), and 0% (LENT-SOMA). Factors, such as age, initial vaginal involvement, and radiation dose were associated with increased toxicity risk. Significant heterogeneity was observed in study populations and methodologies.
Conclusions
Vaginal toxicities are common following definitive chemoradiation in intact cervical cancer patients, with vaginal stenosis being predominant. Standardization of toxicity scoring methods and radiotherapy dose reporting parameters is crucial for accurate comparison and interpretation of findings. Future research should focus on optimizing treatment strategies to minimize vaginal toxicities while maximizing efficacy and patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Cancer Institute, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.
- Jay Prabha Medanta Hospital, Patna, Bihar, India.
- All India Institute of Medical Sciences, Patna, Bihar, India.
Zitieren
APA
Raj, S., Prasad, R. R., & Ranjan, A. (2024). Incidence of vaginal toxicities following definitive chemoradiation in intact cervical cancer: A meta-analysis. Journal of Contemporary Brachytherapy, 16(3), 241-256. https://doi.org/10.5114/jcb.2024.141402
Vancouver
Raj S, Prasad RR, Ranjan A. Incidence of vaginal toxicities following definitive chemoradiation in intact cervical cancer: A meta-analysis. Journal of Contemporary Brachytherapy. 2024;16(3):241-256. doi:10.5114/jcb.2024.141402
BibTeX
@article{Raj2024,
author = {Raj, Shraddha and Prasad, Rajiv Ranjan and Ranjan, Alok},
title = {Incidence of vaginal toxicities following definitive chemoradiation in intact cervical cancer: A meta-analysis},
journal = {Journal of Contemporary Brachytherapy},
year = {2024},
volume = {16},
number = {3},
pages = {241--256},
doi = {10.5114/jcb.2024.141402}
}
EUVIMED